Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXPF3F
|
||||
| Drug Name |
3-(4-(4-chlorophenyl)piperazin-1-yl)-1-phenylpropan-1-one
|
||||
| Synonyms |
CHEMBL424470
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C19H21ClN2O
|
||||
| Canonical SMILES |
Clc1ccc(cc1)N2CCN(CCC(=O)c3ccccc3)CC2
|
||||
| InChI |
InChI=1S/C19H21ClN2O/c20-17-6-8-18(9-7-17)22-14-12-21(13-15-22)11-10-19(23)16-4-2-1-3-5-16/h1-9H,10-15H2
|
||||
| InChIKey |
WSPGJGOBUJGMBV-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | 5-hydroxytryptamine 1A receptor | Target Info | [1587926] | ||
| Sodium-dependent serotonin transporter | Target Info | [1587926] | |||
| NetPath Pathway | TCR Signaling Pathway | ||||
| PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
| 5HT1 type receptor mediated signaling pathwayP04373:5HT1 type receptor mediated signaling pathway | |||||
| 5HT2 type receptor mediated signaling pathway | |||||
| 5HT3 type receptor mediated signaling pathway | |||||
| 5HT4 type receptor mediated signaling pathway | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.